Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rüdiger Hehlmann

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Leukemia|January 13, 2024
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapiesRüdiger Hehlmann, Michael Lauseker
Blood|November 1, 2024
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemiaFrançois Guilhot, Rüdiger Hehlmann
Annals of Hematology|June 3, 2005
Chronic myeloid leukemia: a model for oncologyRüdiger Hehlmann, Ute Berger, Andreas Hochhaus
Seminars in Thrombosis and Hemostasis|May 5, 2006
Diagnosis and therapy of polycythemia veraEva Lengfelder, Kirsten Merx, Rüdiger Hehlmann
Annals of Hematology|March 28, 2015
The interferon-alpha revival in CMLMoshe Talpaz, Jessica Mercer, Rüdiger Hehlmann
Lancet (London, England)|July 31, 2007
Chronic myeloid leukaemiaRüdiger Hehlmann, Andreas Hochhaus, Michele Baccarani, et al.
Expert Opinion on Pharmacotherapy|January 14, 2011
Treatment of chronic myeloid leukemia when imatinib failsRüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saussele
Bone Marrow Transplantation|April 10, 2020
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020)Robert Peter Gale, Rüdiger Hehlmann, Andreas Hochhaus
Journal of Critical Care|October 16, 2004
Management of infections in critically ill neutropenic cancer patientsDieter Buchheidt, Margit Hummel, Georg Engelich, et al.
European Journal of Haematology|April 3, 2004
Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopeniaDieter Buchheidt, Margit Hummel, Steffen Diehl, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Leukemia|January 13, 2024
How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapiesRüdiger Hehlmann, Michael Lauseker
Blood|November 1, 2024
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemiaFrançois Guilhot, Rüdiger Hehlmann
Annals of Hematology|June 3, 2005
Chronic myeloid leukemia: a model for oncologyRüdiger Hehlmann, Ute Berger, Andreas Hochhaus
Seminars in Thrombosis and Hemostasis|May 5, 2006
Diagnosis and therapy of polycythemia veraEva Lengfelder, Kirsten Merx, Rüdiger Hehlmann
Annals of Hematology|March 28, 2015
The interferon-alpha revival in CMLMoshe Talpaz, Jessica Mercer, Rüdiger Hehlmann
Lancet (London, England)|July 31, 2007
Chronic myeloid leukaemiaRüdiger Hehlmann, Andreas Hochhaus, Michele Baccarani, et al.
Expert Opinion on Pharmacotherapy|January 14, 2011
Treatment of chronic myeloid leukemia when imatinib failsRüdiger Hehlmann, Susanne Jung-Munkwitz, Susanne Saussele
Bone Marrow Transplantation|April 10, 2020
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020)Robert Peter Gale, Rüdiger Hehlmann, Andreas Hochhaus
Journal of Critical Care|October 16, 2004
Management of infections in critically ill neutropenic cancer patientsDieter Buchheidt, Margit Hummel, Georg Engelich, et al.
European Journal of Haematology|April 3, 2004
Fatal cerebral involvement in systemic aspergillosis: a rare complication of steroid-treated autoimmune bicytopeniaDieter Buchheidt, Margit Hummel, Steffen Diehl, et al.
Pageof 14